Related Experiment Video
Updated: May 21, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
Published on: May 2, 2018
[Emergence of plasmid mediated AmpC β-lactamasas: Origin, importance, detection and therapeutical options]
Cristina Seral1, María José Gude, F Javier Castillo
1Servicio de Microbiología, Hospital Clínico Universitario Lozano Blesa, Avda San Juan Bosco 15, 50009 Zaragoza, Spain.
Abstract:
AmpC β-lactamases can hydrolyze penicillins, oxyimino-, 7-α-methoxycephalosporins and monobactams. Susceptibility to cefepime or cefpirome is little affected and is unchanged for carbapenems. Originally such genes are thought to have been mobilized to mobile genetic elements from the chromosomal ampC genes from members of Enterobacteriaceae facilitating their spread and now they can appear in bacterial lacking or poorly expressing a chromosomal ampC gene. The prevalence of infection by plasmid mediated AmpC (pAmpC) varies depending on the type of enzyme and geographical location and blaCMY-2 is the most frequently detected worldwide. Typically, pAmpC producing isolates are associated with resistance to multiple antibiotics making the selection of an effective antibiotic difficult. Phenotypic and molecular methods to detect pAmpC are described and the role of different antibiotics in the treatment of these infections is examined. Surveillance studies about the evolution of this emerging resistant mechanism are important in clinical isolates. Evaluate the in vitro susceptibility of these isolates and the clinical efficacy of other therapeutic options is required.
Insights
AmpC beta-lactamases confer resistance to many antibiotics, complicating treatment. Plasmid-mediated AmpC (pAmpC) enzymes, like blaCMY-2, are spreading globally, necessitating surveillance and new therapeutic strategies.
Area of Science:
- Microbiology
- Molecular Biology
- Pharmacology
Context:
- AmpC beta-lactamases hydrolyze a broad spectrum of beta-lactam antibiotics, including penicillins and cephalosporins.
- The spread of plasmid-mediated AmpC (pAmpC) genes, particularly blaCMY-2, is a growing global health concern.
- pAmpC-producing bacteria often exhibit multidrug resistance, limiting effective treatment options.
Purpose:
- To review the characteristics and prevalence of AmpC beta-lactamases, focusing on plasmid-mediated forms.
- To discuss methods for detecting pAmpC enzymes and evaluate antibiotic treatment strategies.
- To highlight the importance of surveillance for emerging resistance mechanisms.
Summary:
- AmpC beta-lactamases hydrolyze key antibiotic classes, with plasmid-mediated variants (pAmpC) spreading globally.
- blaCMY-2 is the most common pAmpC enzyme worldwide, often conferring multidrug resistance.
- Detection methods and treatment efficacy of various antibiotics against pAmpC-producing bacteria are examined.
Impact:
- Understanding pAmpC prevalence and resistance patterns is crucial for guiding clinical treatment decisions.
- Surveillance studies are essential for monitoring the evolution of AmpC-mediated resistance.
- Further evaluation of in vitro susceptibility and clinical efficacy of alternative therapeutics is required.
More Related Videos
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
08:06The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antibiotic Selection
Development of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...